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Abstract: Uremic state and hemobioincompatibility are implicated in subclinical inflammation 
and oxidative stress and progression of atherosclerosis in the hemodialysis (HD) population. 
To what extent different dialysis membranes contribute to oxidative stress induced by a dialysis 
procedure per se is still a subject of debate. Fifteen HD patients and 15 healthy controls were 
enrolled in this study. Patients received two index HD sessions with a cuprophane and poly-
sulfone membrane two weeks apart. Blood samples were collected at baseline and then before 
and after HD sessions. We determined serum thiobarbituric acid, protein carbonyl, and serum 
nitrite/nitrate levels as markers of oxidative damage. We also measured erythrocyte glutathione 
level, catalase, superoxide dismutase and glutathione peroxidase activity, and serum vitamin 
C and E levels as antioxidant markers. At baseline, HD patients, in comparison with normal 
controls, had a trend towards increased oxidant state and depletion of antioxidants. Cuprophane 
dialysis induced a higher increase in production of oxidants, along with a lower compensatory 
increase of antioxidants when compared with polysulfone dialysis. In conclusion, a single HD 
session, even when conducted with a biocompatible membrane, appears to play an important 
role in the imbalance between ROS production and antioxidant defense, but to a milder extent 
than cuprophane dialysis.
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Introduction
Oxidative stress, resulting from an imbalance between reactive oxygen species (ROS) 
and reactive nitrogen species (RNS) production and antioxidant defense mechanisms, 
is a well recognized phenomenon in hemodialysis (HD) patients. There is a growing 
body of evidence implicating increased oxidative stress and inflammation in the genesis 
of cardiovascular atherosclerotic diseases, that are the leading causes of morbidity and 
mortality in the HD population.1 Increased oxidative stress in HD patients may arise 
from uremia-associated metabolic/humoral abnormalities and the bioincompatibility 
of the HD procedure (dialyzer membrane and pyrogen component of the dialyzate).
In normal conditions, free oxygen radicals (such as O2
−, hydoxyl radicals, 
hydroxy peroxide) serve as part of nonspecific defense mechanisms in the organism 
(for instance, against infectious factors); however, they may become toxic when they are 
overproduced or because of alterations in cellular mechanisms of protection.3 Several 
markers of oxidative stress have been identified, such as the lipid peroxidation product, 
malondialdehyde (MDA), advanced glycosylation end products, advanced oxidation 
protein products, and enhanced susceptibility of low-density lipoprotein (LDL) to 
ex vivo oxidation.2,3 Increased RNS also contributes to oxidative stress, as indicated International Journal of Nephrology and Renovascular Disease 2010:3 40
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in one. For recruitment purposes, the following criteria was 
  considered:
1.  Duration of HD of not less than one year.
2.    Hemodialysis treatment three times weekly with a 
  synthetic or semisynthetic membrane, each session lasting 
four hours, with a bicarbonate dialyzate.
3.    Documentation of adequate dialysis based on good clinical 
status, satisfactory laboratory data, and a KT/V value  1.3.
Hemodialysis patients meeting the above criteria were 
dialyzed with a cuprophane membrane in a single HD session, 
then dialyzed using their regular membranes for the following 
two weeks. At the end of this period, they were dialyzed with a 
polysulfone membrane in another single HD session. Venous 
blood samples for oxidative stress markers were taken imme-
diately before and after these two index HD sessions to study 
the effects of the two different dialysis membranes. Oxida-
tive stress parameters were also studied at baseline in blood 
samples of both patient and healthy control groups.
Fifteen individuals (nine men and six women of mean age 
57.3 ± 2.2 years) proven to be healthy and free from any signs of 
chronic disease after careful clinical and laboratory examination 
were included in the study as the control group. Control subjects 
had a mean serum creatinine of 0.77 ± 0.20 mg/dL and were 
considered to be normotensive on the basis of blood pressure 
measurements (mean systolic blood pressure 118 ± 10 mmHg 
and mean diastolic pressure 76 ± 3 mmHg). None of the study 
subjects were active cigarette or alcohol consumers, and those 
who were on pre-existing antioxidant supplements, such as 
vitamin C and E, were excluded from the study.
Determination of oxidative  
stress markers
Fasting blood samples were collected from all subjects without 
an anticoagulant. In HD patients, blood samples were collected 
before the first weekly HD treatment. Serum was obtained by 
centrifugation at 3000 × g for 10 minutes. Hemolysates were 
prepared from samples collected into vacuum tubes containing 
1.7 mg/mL K3 ethylenediamine tetra-acetic acid (EDTA) as an 
anticoagulant. After centrifugation at 3000 × g for 15 minutes, 
plasma and buffy coat were removed from the pellet.
Red blood cells were washed three times in an ice-cold 
isotonic saline (1:10; v/v), and were resuspended in a washing 
solution to give a 50% suspension. Hemolysate obtained was 
divided into two aliquots. One aliquot was used to determine 
the hemoglobin concentration by the cyanomethemoglobin 
method.8 The second aliquot was used for spectrophotometric 
  determination of the enzymatic activities of SOD, CAT, and 
GSH-Px.
by the fact that an impaired nitric oxide (NO) synthetic path-
way plays a key role in mediating renal injury.4 Antioxidant 
mechanisms that serve as a safeguard against highly reactive 
oxygen radicals seem to be impaired in HD patients. These 
may be enzymatic (such as superoxide dismutase [SOD], 
catalase [CAT], and glutathione peroxidase [GSH-Px]) or 
extracellular antioxidant defense elements (such as reduced 
  glutathione [GSH]).5 Furthermore, hydrophilic and lipophilic 
  antioxidant vitamins are altered in uremia, ie, vitamin E levels 
in erythrocytes and mononuclear cells are low despite normal 
plasma levels, and a dramatic depletion of vitamin C is also 
observed.6,7
Uremic state and hemobioincompatibility are now 
regarded as the major culprits responsible for subclinical 
inflammation and oxidative stress and, therefore, progression 
of accelerated atherosclerosis. Measurement of oxidative stress 
could be useful to investigate its role, not only in the initiation 
and development of chronic uremic complications, but also to 
evaluate preventive actions, including antioxidative therapy and 
use of more biocompatible membranes during HD.
The aim of this study was to explore the net oxidative effect 
produced by a single HD procedure, based on a comparison 
of two different dialysis membranes, ie, cellulosic cuprophane 
and synthetic polysulfone in chronic HD patients. We 
  determined serum MDA as an indicator of lipid peroxidation, 
plasma protein carbonyl content (PCO) as a marker of 
  oxidative protein damage, and serum nitrite/nitrate levels as 
indicators of RNS production. We measured erythrocyte GSH 
level, CAT, SOD, and GSH-Px activity, and serum vitamin E 
and vitamin C levels as antioxidant markers.
Methods
The investigation conformed to the principles outlined in 
the Declaration of Helsinki. The study was approved by the 
local ethics committee, and all participants gave informed 
consent.
Subjects and study design
Fifteen nondiabetic HD patients (nine men and six 
women, mean age 58.3 ± 2.3 years, mean HD duration 
38.3 ± 6.7 months) with a history of end-stage renal 
  disease (ESRD), in the absence of any clinical or laboratory 
  documentation of atherosclerotic disease, or systemic 
  pathologies, such as active infection, inflammatory disease, 
or malignancy, were included in this random, cross-controlled 
study. Etiologies for ESRD were primary hypertension 
in 10, nephrolithiasis in two, chronic glomerulonephritis 
in one, polycystic kidney disease in one, and unknown International Journal of Nephrology and Renovascular Disease 2010:3 41
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Serum thiobarbituric acid-reactive substances in serum 
were determined by the fluorometric method,9 and the results 
were expressed as nmol/mL MDA. Carbonyl content in 
oxidatively modified proteins was determined as previously 
described.10 The absorbance of the sample was measured at 
360 nm and the results were given as µmol/L carbonyl using ε 
max 22,000 M−1cm−1. Serum nitrite and nitrate levels were mea-
sured using the methods of Kader and Bories, respectively.11,12 
Serum vitamin E concentration was measured as described 
by Desai using a standard curve of known concentrations 
of D-α-tocopherol acetate.13 Vitamin C concentrations were 
measured in serum by the method of McCormick.14 Ascorbic 
acid was oxidized by Cu2+ to form dehydroascorbic acid which 
reacts with acidic 2,4-dinitrophenylhydrazine to form a red 
bis-hydrozone which was measured at 520 nm. Erythrocyte 
concentration of the reduced GSH was measured using the 
method of Fairbanks and Klee.8 The results were expressed 
as mg/gHb. In the hemolysates obtained as mentioned above, 
the enzymatic activities of SOD, CAT, and GSH-Px were 
measured. The results were expressed as U/gHb for SOD and 
GSH-Px, and as k/gHb for CAT, where k is the rate constant for 
CAT activity. Erythrocyte Cu, Zn-SOD activity was assayed by 
the spectrophotometric indirect inhibition technique of Misra 
and Fridovic.15 CAT activity in erythrocytes was measured 
by the method described by Aebi using hydrogen peroxide 
as substrate.16 GSH-Px activity was measured in erythrocytes 
using t-butyl hydroperoxide as a substrate.17
Statistical analysis
Statistical analysis was performed using SPSS software 
(SPSS 10.0 for Windows [SPSS/PC; SPSS Inc., Chicago, 
IL]). Continuous variables were expressed as mean ± standard 
error of measurement (SE). The independent t-test and paired 
t-test were used to compare the means for continuous variables 
with normal distribution. The Mann-Whitney U test and 
Wilcoxon test were used for the analysis of data with non-
normal distribution. P  0.05 was considered statistically 
significant.
Results
Patient and control groups did not differ significantly from 
each other with respect to age and gender, as described in 
the Methods section.
Baseline oxidative stress and antioxidant parameters are 
shown in Table 1. When compared with the control group, HD 
patients had statistically higher levels of MDA, an indicator 
of lipid peroxidation, and higher protein carbonyl content, an 
indicator of oxidative protein damage. Plasma nitrite levels 
were increased in uremic patients, whereas no significant 
change was observed in nitrate levels between the groups.
No significant difference was observed in serum GSH 
levels and vitamin E levels between the groups; however, the 
vitamin C level was found to be higher in the HD group. Anti-
oxidant enzymes, including SOD and GSH-Px, were lower in 
patients undergoing HD compared with controls, as opposed to 
the CAT level which was found to be higher in HD patients.
Effect of dialysis with cuprophane 
membrane on oxidative stress
The changes in oxidative stress parameters after a HD session 
using the cuprophane membrane are shown in Table 2. Both 
Table 1 Comparison of HD patients and healthy controls with 
respect to baseline oxidative stress parameters (mean ± SE)
Controls  
(n = 15)
HD patients  
(n = 15)
P
MDA, nmol/mL 1. 09 ± 0.04 1.35 ± 0.04 0.01
PCO, µmol/L 55.7 ± 1.3 73.87 ± 3.9 0.000
GSH, mg/gHb 2.45 ± 0.09 2.68 ± 0.10 0.12
Vit C, mg/dL 0.59 ± 0.07 1.81 ± 0.16 0.000
Vit E, µmol/L 57.9 ± 0.07 53.6 ± 1.35 0.082
SOD, U/gHb) 1703 ± 32 1116 ± 24 0.000
CAT, k/gHb 248 ± 14 261 ± 8.5 0.000
GSH-Px, U/gHb 2.68 ± 0.10 1.87 ± 0.09 0.000
Nitrite, µmol/L 0.64 ± 0.02 2.36 ± 0.12 0.000
Nitrate, nmol/L 1.14 ± 0.01 0.18 ± 0.01 0.108
Abbreviations: HD, hemodialysis; MDA, malondialdehyde; PCO, protein carbonyl 
content; GSH, glutathione; GSH-Px, GSH peroxidase; vit C, vitamin C; vit E, vitamin E; 
SOD, superoxide dismutase; CAT, catalase.
Table 2 Changes in oxidative stress parameter levels in patients 
using a cuprophane membrane, before and after a HD session 
(mean ± SE)
  Before HD After HD P
MDA, nmol/mL 1.35 ± 0.08 1.62 ± 0.07 0.000
PCO, µmol/L 73.8 ± 3.9 79.1 ± 3.7 0.038
GSH, mg/gHb 2.68 ± 0.10 2.42 ± 0.08 0.019
Vit C, mg/dL 1.81 ± 0.16 0.97 ± 0.09 0.001
Vit E, µmol/L 53.6 ± 1.35 53.4 ± 1.74 0.926
SOD, U/gHb) 1116 ± 24 1213 ± 98 0.000
CAT, k/gHb 261 ± 8.5 287 ± 11 0.005
GSH-Px, U/gHb 1.87 ± 0.09 2.19 ± 0.09 0.000
Nitrite, µmol/L 2.36 ± 0.12 1.94 ± 0.11 0.000
Nitrate, nmol/L 0.18 ± 0.01 0.09 ± 0.008 0.000
Abbreviations: HD, hemodialysis; MDA, malondialdehyde; PCO, protein carbonyl 
content; GSH, glutathione; GSH-Px, GSH peroxidase; vit C, vitamin C; vit E, vitamin E; 
SOD, superoxide dismutase; CAT, catalase.International Journal of Nephrology and Renovascular Disease 2010:3 42
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MDA and PCO levels were found to be significantly increased 
after a dialysis procedure with the cuprophane membrane. Serum 
GSH and vitamin C levels were found to be decreased, whereas 
no change was observed in vitamin E levels, after a HD procedure 
using the cuprophane membrane. As for the antioxidant enzymes, 
SOD, CAT, and GSH-Px levels were all significantly increased at 
the end of the HD session. Serum nitrite and nitrate levels were 
found to be decreased at the end of dialysis.
Effect of dialysis with polysulfone 
membrane on oxidative stress
The changes in oxidative stress parameters after a HD session 
with a polysulfone membrane are shown in Table 3. Both 
MDA and PCO levels were found to be higher after a dialysis 
session with the polysulfone membrane; however, the increase 
in PCO level did not reach statistical significance. Serum GSH 
and vitamin C levels were found to be decreased, whereas an 
increase was observed in vitamin E levels, after an HD proce-
dure with the polysulfone membrane. The levels of antioxidant 
enzymes, including SOD, CAT, and GSH-Px, were all signifi-
cantly increased during that HD session, similar to what was 
observed using the cuprophane membrane. Serum nitrite and 
nitrate levels were found to be decreased in the same session, 
as was the case with the cuprophane membrane.
Comparison of the impacts of two 
different dialysis membranes  
on oxidative stress
Comparison of the changes in oxidative stress parameter levels 
(∆ levels) using cuprophane and polysulfone membranes after 
an HD session is shown in Table 4. A dialysis session with 
the cuprophane membrane was found to cause a significantly 
greater increase in MDA levels when compared with the 
  polysulfone membrane. There was no difference in PCO levels 
between the two dialysis membranes. A dialysis session with 
the polysulfone membrane was found to lower GSH levels 
much more than the cuprophane membrane. On the other 
hand, an increase in vitamin E levels was observed using the 
polysulfone membrane, an effect which was absent with the 
cuprophane membrane. No significant change was observed 
in vitamin C levels between the two membranes. There 
were also no significant differences in SOD and GSH-Px 
levels between the polysulfone and cuprophane membranes. 
However, dialysis with the polysulfone membrane caused 
a significantly greater increase in CAT levels than with the 
cuprophane membrane. There were no differences in nitrite 
and nitrate levels between the two membranes.
Discussion
This study was performed to analyze whether a single dialysis 
procedure induces a respective net oxidative balance, based 
on a comparison of two dialysis membranes with different 
biocompatibility features, ie, cuprophane and polysulfone, 
in chronic HD patients. Our major finding was that a single 
dialysis session, even with a biocompatible membrane such 
as polysulfone, contributes to oxidant/antioxidant imbalance, 
but to a milder extent than cuprophane dialysis.
We have shown that a dialysis session with a cuprophane 
or polysulfone membrane caused increased levels of MDA, an 
index of lipid peroxidation. However, the increase was more 
Table 3 Changes in oxidative stress parameter levels in patients 
using a polysulfone membrane, before and after a HD session 
(mean ± SE)
Before HD After HD P
MDA, nmol/mL 1.25 ± 0.04 1.34 ± 0.04 0.000
PCO, µmol/L 72.1 ± 3.5 78.7 ± 5.6 0.303
GSH, mg/gHb 2.58 ± 0.10 2.01 ± 0.07 0.000
Vit C, mg/dL 2.07 ± 0.12 1.01 ± 0.09 0.000
Vit E, µmol/L 53.2 ± 1.35 57.7 ± 1.12 0.000
SOD, U/gHb) 1130 ± 24 1220 ± 34 0.000
CAT, k/gHb 235 ± 18 353 ± 36 0.000
GSH-Px, U/gHb 2.07 ± 0.08 2.43 ± 0.15 0.002
Nitrite, µmol/L 1.79 ± 0.09 1.42 ± 0.09 0.002
Nitrate, nmol/L 0.22 ± 0.02 0.12 ± 0.01 0.006
Abbreviations: HD, hemodialysis; MDA, malondialdehyde; PCO, protein carbonyl 
content; GSH, glutathione; GSH-Px, GSH peroxidase; vit C, vitamin C; vit E, vitamin E; 
SOD, superoxide dismutase; CAT, catalase.
Table 4 Comparison of the changes in oxidative stress parameter 
levels (∆ levels) using cuprophane and polysulfone membranes after 
a HD session (mean ± SE)
Polysulfone Cuprophane P
MDA, nmol/mL 0.09 ± 0.003 0.27 ± 0.03 0.000
PCO, µmol/L 6.61 ± 6.2 5.3 ± 2.3 0.843
GSH, mg/gHb −0.57 ± 0.08 −0.26 ± 0.09 0.024
Vit C, mg/dL −1.06 ± 0.15 −0.84± 0.19 0.372
Vit E, µmol/L 4.5 ± 0.40 −0.2 ± 1.92 0.032
SOD, U/gHb) 90 ± 15 97 ± 12 0.730
CAT, k/gHb 118 ± 30 26 ± 7.6 0.009
GSH-Px, U/gHb 0.36 ± 0.09 0.32 ± 0.16 0.529
Nitrite, µmol/L −0.37 ± 0.09 −0.42 ± 0.08 0.717
Nitrate, nmol/L −0.10 ± 0.03 −0.09 ± 0.01 0.581
Abbreviations: HD, hemodialysis; MDA, malondialdehyde; PCO, protein carbonyl 
content; GSH, glutathione; GSH-Px, GSH peroxidase; vit C, vitamin C; vit E, vitamin E; 
SOD, superoxide dismutase; CAT, catalase.International Journal of Nephrology and Renovascular Disease 2010:3 43
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marked with cuprophane than with polysulfone. Although 
there are controversial results in the literature indicating that 
HD could improve lipid profiles in patients with a previous 
pro-oxidative state such as uremia,18 our findings are in 
accordance with the findings of others who have indicated 
an increase in lipid peroxidation during dialysis.19 Interaction 
of circulating blood with the hemodialytic system causes 
bioincompatibility reactions, such as production of ROS 
by inflammatory cells due to complement-dependent or 
complement-independent pathways.19 The ultimate result 
is an increase in inflammatory reactions characterised by 
triggering of a respiratory burst, and synthesis and release 
of inflammatory mediators. Plasma levels of inflammatory 
cytokines (such as interleukin-1, interleukin-6, and tumor 
necrosis factor-α) are elevated in dialysis patients, and 
their expression was exacerbated further even after a single 
dialysis.20 The majority of ROS generated from activated 
polymorphonuclear leukocytes is hydrogen peroxide which 
causes subsequent lipid peroxidation. Oxidative stress and 
alterations in lipid metabolism observed in HD are important 
because it enhances the susceptibility of LDL oxidation 
which is recognised as the major initiating event in the genesis 
of atherosclerosis. Besides the alterations in lipid levels, 
oxidative stress also involves protein moieties in uremic 
patients.21 We found PSO, an indicator of oxidative protein 
damage, to be higher in HD patients compared with controls. 
PCO level increased after a dialysis procedure with both 
membranes, although it did not reach statistical significance 
with the polysulfone membrane. The levels of difference in 
PCO content between groups was similar, indicating that 
both dialysis membrane types may contribute to increased 
oxidative stress at the protein level as well.
Plasma nitrite levels were found to be higher in HD 
patients than in normal controls, indicating a high RNS 
production in the uremic population. NO actively reacts with 
superoxide (O2
−) and other ROS to produce peroxynitrite, a 
highly cytotoxic ROS. Peroxynitrite was shown to induce oxi-
dative damage to DNA, lipids, and proteins in vascular cells, 
all of which contribute to cellular damage and progression 
of atherosclerosis.22 A putative cause for excessive NO 
production in uremia could be guanidino compounds 
that accumulate in the circulation of uremic patients and 
  upregulate NO synthesis. Another possible cause of increased 
NO is its higher release from systemic vessels due to aug-
mented expression of both inducible and endothelial nitric 
oxide synthase. Most studies indicate that NO increases 
early during dialysis, possibly due to heparin or leukocyte 
  activation by the dialysis membrane, both of which are 
potential inducers of NO production; however, a significant 
drop in NO levels usually occurs at the end of dialysis.23 As 
opposed to increased postdialysis levels of other oxidants, 
such as MDA and PCO, we have found postdialysis nitrite and 
nitrate levels to be lower than predialysis values, indicating 
that NO elimination during dialysis prevails production and 
returns to high levels between HD sessions.
Our results indicate that, with the exception of CAT, anti-
oxidant enzymes (SOD and GSH-Px) representing the early 
lines of defense against oxidative attack, are lower in patients 
undergoing HD compared with healthy controls. This finding 
is confirmed by other research.24 Some studies have indicated 
impairment of antioxidant systems and augmentation of 
oxidants during HD sessions.25 Our results show that all 
antioxidant enzymes (including SOD, CAT, and GSH-Px) 
were significantly increased after an HD session. The level 
of increase was not different for SOD and GSH-Px between 
the two type of membranes; however, CAT levels increased 
more with the polysulfone membrane. These results suggest 
that the increase in oxidant products after a dialysis session 
is accompanied by compensatory increases in the antioxidant 
mechanism of erythrocytes in scavenging ROS. However, that 
mechanism is not sufficient to restore the balance, reflecting 
compromised antioxidant defense. Interestingly, we found 
that GSH levels, which were similar at baseline between 
patients and controls, were decreased after a dialysis. The 
observed decrease in intracellular GSH during a dialysis ses-
sion points to either a consumption or a loss of GSH during 
dialysis, rather than to an effect of uremia.26
We have found vitamin C levels to be higher in HD 
patients compared with normal subjects. However, vitamin E 
levels did not differ between the groups. Most other studies 
have found plasma vitamin E levels to be normal but vitamin 
C levels to be reduced in uremic subjects.27 The unexpectedly 
high vitamin C levels in HD patients in this study suggests 
that vitamin C concentration might have increased in excess 
of other uremic pro-oxidant substances. Metabolites have 
been reported to be derived from ascorbic acid oxidation 
during HD, with a significant increase in ascorbyl-free 
radicals.23 The ratio of ascorbic acid to oxidised ascorbic 
acid is usually tightly regulated, which is further supported 
by the presence of high ascorbate concentrations in tissues 
with relatively high fluxes of oxidants.28 The high vitamin C 
levels observed in the HD patients in our study need to 
be confirmed by further studies. Vitamin C is an effective 
antioxidant against lipid peroxidation because of its ability 
to destroy free radicals and regenerate α-tocopherol from 
tocopherol radicals. In accordance with other studies,7 we International Journal of Nephrology and Renovascular Disease 2010:3 44
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have found postdialysis vitamin C levels to be decreased by 
almost 50%, which is likely to be due to the filtration of this 
low molecular weight compound through the membrane. 
On the other hand, lipophilic vitamin E is not filtered by the 
membrane. Our findings indicate an increase in vitamin E 
levels using a polysulfone membrane, an effect which was 
absent with a cuprophane membrane. In uremia, vitamin E 
levels in erythrocytes and mononuclear cells have been shown 
to be low despite normal plasma levels,6 in agreement with 
our work showing comparable serum levels of vitamin E 
in both uremic patients and control groups. Although other 
studies indicate that vitamin E concentration is not modified 
by HD,23 our finding of increased concentration of vitamin E 
raises the possibility that the polysulfone membrane might 
have increased the bioactivity of vitamin E in the setting of 
more favorable hemobiocompatibility.
Our results have also shown that HD patients had a trend 
towards increased oxidant state and depletion of antioxidants 
in comparison with normal controls. In our previous study, 
we demonstrated increased oxidative status and a defective 
antioxidative defense system starting from the early stages 
of chronic renal failure,5 showing that defence mechanism 
impairment is, at least in part, independent of the dialysis 
procedure. Overall, the absence of complete correction 
of uremia together with untoward effects of dialysis can 
lead to oxidative stress caused by abnormal production of 
  oxidants and defective antioxidant protection. The degree of 
HD-associated increase in oxidative stress varies according 
to the dialysis membrane used. It was previously reported 
that, with respect to induction of oxidative DNA damage 
and MDA formation, polysulfone and cellulosic membranes 
  maximally differed by about 50 and 70 percent, respectively.29 
Moreover, some studies point out that polysulfone improves 
the ROS/antioxidant ratio.24
In conclusion, HD patients face marked disturbance in 
the extracellular redox system in the setting of uremia, which 
is exacerbated by a dialysis procedure. A single HD session, 
even when conducted with a biocompatible membrane, 
appears to play an important role in the imbalance between 
ROS production and antioxidant defense. Therefore, it is 
worthy of consideration that increased oxidative stress is an 
important therapeutic target for pharmacologic therapy and 
palliation of hemoincompatibility of a dialysis system in 
uremic patients undergoing HD.
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